Baxter teams up with Northwestern:
A treatment that uses adult stem cells to rebuild failing hearts reduced chest pain and improved activity levels for severely ill patients one year after injection, a Northwestern University researcher working with a Chicago-area device-maker reported.Though still in early development stages, the work of Dr. Douglas Losordo, using technology developed by Baxter International Inc., is being watched closely by the stem cell research community. The trial data, presented Tuesday at the American Heart Association scientific conference in Orlando, Fla., is also important in the study of heart disease.
No, they don't need taxpayers to fund speculative research because the use of adult stem cells has time and again yielded beneficial therapies. To be blunt, this research is viable, is likely to benefit people and carries a real financial incentive.
[Note that the use of adult stem cells does not involve the destruction of a human life.]
Recent Comments
Prachi: "My son , 25 yrs old is an ..."
Anon: "Thanks for explaining that, I appreciate it. I ..."
ELyse Miriam: "Dear Anon, you raise a very important question ..."
Ed: "Joanne, you might not have seen evidence spelled ..."
Anon.: "PLEASE READ!!! This doesn't actually have anything to ..."
Joanne: "The heading "ARTL questions Palin's pro-life credentials" led ..."
Matt: "I am a veteran. Though I've been in ..."